CURRENT NEWS

• 23.06.2022
  BioAgilytix Appoints Christie Knittel Mabry as New Chief People Officer
• 23.06.2022
  MDGH Update - June 2022
• 23.06.2022
  Almac Diagnostic Services Collaborates with AstraZeneca to Develop and Commercialise Companion Diagnostics (CDx)
• 23.06.2022
  New Data from Our Liver Imaging Method Study Presented at EASL's International Liver Congress 2022
• 23.06.2022
  Amyris Barra Bonita Fermentation Plant Begins Industrial Production
• 23.06.2022
  Quotient Limited Announces Proposed Underwritten Offering
• 23.06.2022
  Patients With Uveal Melanoma Tested With DecisionDx-UM Report Gaining Value From Test Results in Study Conducted in Collaboration With the Melanoma Research Foundation's CURE OM Initiative
• 23.06.2022
  Myriad Genetics Teams Up With Epic to Make Genetic Testing Accessible to More Patients With Electronic Health Record (EHR) Integration
• 23.06.2022
  AbbVie Declares Quarterly Dividend
• 23.06.2022
  Neptune Wellness Solutions Inc. Closes $5 Million Registered Direct Offering
• 23.06.2022
  Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central
• 23.06.2022
  BioNTech Receives Priority Medicines (PRIME) Designation From EMA for Enhanced Regulatory Support of CAR-T Candidate BNT211 in Testicular Cancer
• 23.06.2022
  Pfizer Declares Third-Quarter 2022 Dividend
• 23.06.2022
  Strata Oncology Expands Sentinel Trial With Lehigh Valley Topper Cancer Institute and University of Michigan Health Rogel Cancer Center to Bring Precision Therapies to Patients Earlier in Their Cancer Journey
• 23.06.2022
  CNS Pharmaceuticals Receives Approval From U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
• 23.06.2022
  Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
• 23.06.2022
  Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-2059, an Investigational Small Molecule-Based Radiopharmaceutical Targeting Solid Tumors Expressing NTSR1
• 23.06.2022
  Telix and Isologic Sign License and Distribution Agreement for Illuccix for Canada
• 23.06.2022
  Fujirebio Acquires ADx Neurosciences and Confirms Its Intentions to Bring Better and Earlier Neurodegenerative Disease Diagnostic Solutions to the Global Diagnostics Industry
• 23.06.2022
  Manufacturing Strain of Kyowa Hakko Bio's 2'-Fucosyllactose, a Human Milk Oligosaccharide (HMO), Passed Safety Evaluation in China

Records per page:

Page

Total: 24138 records.